Sedat Evran
Insider
First SEC filing: Sept. 14, 2023 · Latest: Sept. 14, 2023
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 6, 2026 | BIO | M | 864 | · | · | 3,880 Direct | +28.65% | Acquired | (price as of 2026-10-02) |
| Sept. 6, 2026 | BIO | F | 277 | $386.11 | $106,952 | 3,603 Direct | -7.14% | Disposed | -4.4% (price as of 2026-10-02) |
| Sept. 6, 2026 | BIO | M | 864 | · | · | 1,728 Direct | -33.33% | Disposed | (price as of 2026-10-02) |
| Sept. 5, 2026 | BIO | M | 1,027 | · | · | 3,345 Direct | +44.31% | Acquired | (price as of 2026-10-02) |
| Sept. 5, 2026 | BIO | F | 329 | $386.11 | $127,030 | 3,016 Direct | -9.84% | Disposed | -4.4% (price as of 2026-10-02) |
| Sept. 5, 2026 | BIO | M | 1,027 | · | · | 3,083 Direct | -24.99% | Disposed | (price as of 2026-10-02) |
| Sept. 4, 2026 | BIO | A | 4,026 | · | · | 4,026 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 20, 2025 | BIO | M | 1,044 | · | · | 2,568 Direct | +68.50% | Acquired | (price as of 2026-10-02) |
| Oct. 20, 2025 | BIO | F | 335 | $321.90 | $107,836 | 2,233 Direct | -13.05% | Disposed | 14.7% (price as of 2026-10-02) |
| Oct. 20, 2025 | BIO | M | 1,044 | · | · | 2,088 Direct | -33.33% | Disposed | (price as of 2026-10-02) |
| Sept. 6, 2025 | BIO | M | 864 | · | · | 1,801 Direct | +92.21% | Acquired | (price as of 2026-10-02) |
| Sept. 6, 2025 | BIO | F | 277 | $295.43 | $81,834 | 1,524 Direct | -15.38% | Disposed | 25.0% (price as of 2026-10-02) |
| Sept. 6, 2025 | BIO | M | 864 | · | · | 2,592 Direct | -25.00% | Disposed | (price as of 2026-10-02) |
| Sept. 5, 2025 | BIO | A | 4,110 | · | · | 4,110 Direct | · | Acquired | (price as of 2026-10-02) |
| March 3, 2025 | BIO | A | 2,918 | · | · | 2,918 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 20, 2024 | BIO | M | 1,044 | · | · | 3,132 Direct | -25.00% | Disposed | (price as of 2026-10-02) |
| Oct. 20, 2024 | BIO | F | 335 | $346.37 | $116,034 | 853 Direct | -28.20% | Disposed | 6.6% (price as of 2026-10-02) |
| Oct. 20, 2024 | BIO | M | 1,044 | · | · | 1,188 Direct | +725.00% | Acquired | (price as of 2026-10-02) |
| Sept. 6, 2024 | BIO | A | 3,456 | · | · | 3,456 Direct | · | Acquired | (price as of 2026-10-02) |
| March 8, 2024 | BIO | A | 3,535 | · | · | 3,535 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 20, 2023 | BIO | A | 4,176 | · | · | 4,176 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 6, 2026 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 864 | Disposed |
| Sept. 5, 2026 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 1,027 | Disposed |
| Sept. 4, 2026 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 4,026 | Acquired |
| Oct. 20, 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 1,044 | Disposed |
| Sept. 6, 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 864 | Disposed |
| Sept. 5, 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 4,110 | Acquired |
| March 3, 2025 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock | $256.45 | March 3, 2035 | 2,918 | Acquired |
| Oct. 20, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 1,044 | Disposed |
| Sept. 6, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 3,456 | Acquired |
| March 8, 2024 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock | $343.76 | March 8, 2034 | 3,535 | Acquired |
| Oct. 20, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 4,176 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Sept. 14, 2023 | BIO | Bio-Rad A Common Stock | 20 | Direct |